首荟通便胶囊通过调节肠道菌群改善洛哌丁胺诱导的大鼠便秘
本研究以洛哌丁胺诱导的SD雄性大鼠便秘模型为对象,灌胃给予首荟通便胶囊(35、70 mg/kg体重,每日三次),评估其对便秘症状的改善作用及与肠道菌群的关系。结果显示首荟通便胶囊可缓解体重下降、胃排空率降低和粪便含水量减少,改善小肠病理损伤,增加Lactobacillus相对丰度及F/B比值,并提高乙酸和丙酸含量。结论认为其通过重塑肠道菌群结构和调节肠道代谢产物来改善便秘。
要点
- 首荟通便胶囊可改善洛哌丁胺诱导的大鼠便秘症状。
- 其机制可能与增加Lactobacillus丰度及F/B比值有关。
- 乙酸和丙酸含量升高提示肠道代谢产物参与调节。
核心结论
- 首荟通便胶囊通过重塑肠道微生物群落结构和调节肠道代谢产物产生来改善洛哌丁胺诱导的大鼠便秘。
研究设计与样本
- 采用洛哌丁胺(1.5 mg/kg体重)诱导SD雄性大鼠便秘模型,造模成功后灌胃给予首荟通便胶囊(35、70 mg/kg体重),每日三次。
- 每周评估体重、胃排空率、粪便含水量及湿/干重,采用H&E染色观察小肠,16SrRNA基因测序分析结肠内容物菌群,GCMS分析短链脂肪酸含量。
主要发现
- 首荟通便胶囊可缓解洛哌丁胺诱导的便秘大鼠体重下降、胃排空率降低和粪便含水量减少。
- H&E染色显示首荟通便胶囊显著改善小肠病理损伤。
- 首荟通便胶囊增加Lactobacillus相对丰度及Firmicutes与Bacteroides比值(F/B)。
- 便秘大鼠给予首荟通便胶囊后乙酸和丙酸含量显著增加。
临床怎么用
- 首荟通便胶囊在动物模型中显示通过调节肠道菌群改善便秘的作用,提示其可能用于便秘治疗,但临床适用需结合患者具体情况。
局限性
- 本研究为动物实验,结果不能直接推广至临床人群。
- 原文未报告样本量、具体统计值及剂量-效应关系等细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Shouhui tongbian capsule (SHTC) is a commercial Chinese patent medicine used in the treatment of constipation. However, its mechanism of action remains unclear. AIM OF THE STUDY: The present study was undertaken to assess SHTC relieved effects on the clinical symptoms of loperamide (LOP) induced constipation in Sprague Dawley (SD) rat model and to clarify the relationship between the protective effect of SHTC on constipation and the gut microbiota. MATERIALS AND METHODS: Constipation male SD rats models were induced with solution of LOP (1.5 mg/kg bw), and rats were treated with an oral dose of SHTC (35, 70 mg/kg bw) three times a day after successful modeling. All rats were assessed weekly by change in body weight, gastric emptying rate, fecal moisture content and wet/dry weight. Hematoxylin and eosin (H&E) were used to observe parts of the rats small intestine. The gut microbiota in colonic contents was analyzed using 16SrRNA gene sequencing. Contents of short-chain fatty acids (SCFAs) were analyzed by gas chromatography-mass spectrometer (GCMS). RESULTS: The results confirmed the therapeutic effects of SHTC on constipation. Specifically, SHTC could alleviate the decrease in body weight, gastric emptying rate and fecal moisture content caused by LOP-induced constipation. The pathological damage of small intestine was significantly improved by H&E staining. Notably, SHTC increased the relative abundances of Lactobacillus and the ratio of Firmicutes to Bacteroides (F/B). In addition, the content of acetic acid and propionic acid was significantly increased in constipated rats fed with SHTC. CONCLUSION: SHTC could ameliorate the development of LOP-induced constipation in rats by remodeling the structure of gut microbial community and regulating production of intestinal metabolites.
引用
- Lin Q, Liu M, Erhunmwunsee F, et al. Chinese patent medicine shouhui tongbian capsule attenuated loperamide-induced constipation through modulating the gut microbiota in rat. J Ethnopharmacol. 2022. PMID: 35934189. doi:10.1016/j.jep.2022.115575
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。